activins has been researched along with Non-alcoholic Fatty Liver Disease in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (83.33) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Chrysafi, P; Eslam, M; George, J; Guatibonza-Garcia, V; Katsarou, A; Kouvari, M; Mantzoros, CS; Markakis, G; Mingrone, G; Mylonakis, SC; Papatheodoridis, G; Valenzuela-Vallejo, L; Verrastro, O | 1 |
| El-Kerdasy, HI; Hussien, NI; Ibrahim, ME | 1 |
| Castanas, E; Kampa, M; Kiagiadaki, F; Kouroumalis, E; Notas, G; Voumvouraki, A | 1 |
| Bian, DX; Jia, L; Liu, J; Liu, YL; Lou, GQ; Luo, Y; Ma, XJ; Shi, JP; Wang, Y; Xun, YH; Yang, WJ; Ye, DW; Zhou, G; Zhu, ML; Zhuang, ZJ | 1 |
| Avó, LR; Bueno, PG; Leal, AM; Nonaka, KO; Selistre-Araújo, HS; Silva, RN | 1 |
| Anastasilakis, AD; Kountouras, J; Mantzoros, CS; Polyzos, SA; Triantafyllou, GΑ | 1 |
6 other study(ies) available for activins and Non-alcoholic Fatty Liver Disease
| Article | Year |
|---|---|
Circulating hormones in biopsy-proven steatotic liver disease and steatohepatitis: A Multicenter Observational Study.
Topics: Activins; Adiponectin; Biopsy; Fibrosis; Follistatin; Growth Differentiation Factor 15; Humans; Insulin; Insulin-Like Growth Factor I; Leptin; Non-alcoholic Fatty Liver Disease | 2023 |
Protective effect of rimonabant, a canabinoid receptor 1 antagonist, on nonalcoholic fatty liver disease in a rat model through modulation of the hepatic expression of activin A and follistatin.
Topics: Activins; Animals; Biomarkers; Cannabinoid Receptor Antagonists; Cytoprotection; Disease Models, Animal; Follistatin; Gene Expression Regulation; Liver; Male; Non-alcoholic Fatty Liver Disease; Oxidative Stress; Piperidines; Pyrazoles; Rats; Rats, Sprague-Dawley; Receptor, Cannabinoid, CB1; Rimonabant; RNA, Messenger; Transforming Growth Factor beta | 2017 |
Activin-A causes Hepatic stellate cell activation via the induction of TNFα and TGFβ in Kupffer cells.
Topics: Activins; Aged; Animals; Case-Control Studies; Fibrosis; Hepatic Stellate Cells; Humans; Kupffer Cells; Liver; Liver Cirrhosis; Male; Mice; Mice, Inbred BALB C; Middle Aged; Non-alcoholic Fatty Liver Disease; Transforming Growth Factor beta; Tumor Necrosis Factor-alpha | 2018 |
Toll-like receptor-4 signalling in the progression of non-alcoholic fatty liver disease induced by high-fat and high-fructose diet in mice.
Topics: Activins; Animals; Dietary Fats; Dietary Sucrose; Fructose; Gene Expression Regulation; Interferon Regulatory Factor-3; Interferon Regulatory Factor-7; Mice; Mice, Knockout; Myeloid Differentiation Factor 88; Non-alcoholic Fatty Liver Disease; Signal Transduction; Toll-Like Receptor 4; Tumor Necrosis Factor-alpha | 2014 |
Effect of physical training on liver expression of activin A and follistatin in a nonalcoholic fatty liver disease model in rats.
Topics: Activins; Animals; Blood Glucose; Body Weight; Diet, High-Fat; Disease Models, Animal; Exercise Therapy; Fatty Liver; Follistatin; Gene Expression; Male; Non-alcoholic Fatty Liver Disease; Obesity; Physical Exertion; Random Allocation; Rats, Wistar; RNA, Messenger; Swimming | 2014 |
Activin A and follistatin in patients with nonalcoholic fatty liver disease.
Topics: Activins; Adiposity; Aging; Biopsy; Body Mass Index; Case-Control Studies; Fatty Liver; Female; Follistatin; Humans; Liver Function Tests; Male; Middle Aged; Non-alcoholic Fatty Liver Disease; Obesity; Sex Characteristics | 2016 |